Sign In
Buy ATRC
$26.20
+0.340 (+1.31%)
At Close: Jun 03, 2026
Acutus Medical Files For IPO For Commercialization Push
02:47pm, Thursday, 23'rd Jul 2020
Acutus Medical has filed to raise $75 million in a U.S. IPO, although the final figure may differ.
Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for
04:31pm, Tuesday, 21'st Jul 2020
AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
$34.56 Million in Sales Expected for AtriCure Inc. (NASDAQ:ATRC) This Quarter
02:28am, Monday, 13'th Jul 2020
Wall Street analysts forecast that AtriCure Inc. (NASDAQ:ATRC) will announce sales of $34.56 million for the current quarter, according to Zacks. Five analysts have provided estimates for AtriCure’s
AtriCure to Announce Second Quarter 2020 Financial Results
12:00pm, Tuesday, 07'th Jul 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2020
Xenon Lights Market Trajectory & Analytics to 2027 - COVID-19 Updated - ResearchAndMarkets.com
12:00am, Tuesday, 07'th Jul 2020
The
Is Apple about to buy smart speaker giant Sonos?
08:46am, Tuesday, 23'rd Jun 2020
A Sonos-Apple allegiance could be on the cards
Hedge Funds Are Buying AtriCure Inc. (ATRC)
04:45pm, Friday, 19'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Edited Transcript of ATRC earnings conference call or presentation 29-Apr-20 8:30pm GMT
05:43pm, Monday, 18'th May 2020
Q1 2020 AtriCure Inc Earnings Call
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
